Veraxa Biotech AG - Post de-SPAC (VRXA) Insider Trading -- Recent Executive & Director Transactions
3 insiders reported 3 Form 4 transactions for Veraxa Biotech AG - Post de-SPAC (VRXA) over the past 18 months (most recent 2026-09-29). Recent activity: Hosseinion Warren (Director) Buy 6,024 shares, Antz Christoph Rudiger (Chief Executive Officer) Buy 5,000 shares, Baumann Oliver Rolf (Director) Buy 50,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-29 | Hosseinion Warren | Director | Buy | 6,024 | $10,060 |
| 2026-08-31 | Antz Christoph Rudiger | Chief Executive Officer | Buy | 5,000 | $7,650 |
| 2026-08-31 | Baumann Oliver Rolf | Director | Buy | 50,000 | $75,000 |
Source: SEC Form 4 filings · as of 2026-09-29